Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV

BACKGROUND. Highly effective hepatitis C virus (HCV) therapies have spurred a scale-up of treatment to populations at greater risk of reinfection after sustained virologic response (SVR). Reinfection may be higher in HIV–HCV coinfection, but prior studies have considered small selected populations....

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Jim, Rossi, Carmine, Gill, John, Walmsley, Sharon, Cooper, Curtis, Cox, Joseph, Martel-Laferriere, Valerie, Conway, Brian, Pick, Neora, Vachon, Marie-Louise, Klein, Marina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399935/
https://www.ncbi.nlm.nih.gov/pubmed/28199495
http://dx.doi.org/10.1093/cid/cix126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399935/
https://www.ncbi.nlm.nih.gov/pubmed/28199495
http://dx.doi.org/10.1093/cid/cix126

Ejemplares similares